Community treatment orders and antipsychotic long-acting injections

British Journal of Psychiatry

Volumn 195, Issue SUPPL. 52, 2009, Pages

  Lambert, Tim J ^a   Singh, Bruce S ^b   Patel, Maxine X ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AUSTRALIA; GROUP THERAPY; HUMAN; INJECTION; MENTAL HEALTH CARE; PRESCRIPTION; REVIEW; SCHIZOPHRENIA; TREATMENT REFUSAL; ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; DELAYED RELEASE FORMULATION; FEMALE; FORENSIC PSYCHIATRY; LEGAL ASPECT; MALE; MANDATORY PROGRAM; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRALIA; CHI-SQUARE DISTRIBUTION; COMMITMENT OF MENTALLY ILL; COMMUNITY MENTAL HEALTH SERVICES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS; MALE; MANDATORY PROGRAMS; PATIENT COMPLIANCE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 71249150348     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.195.52.s57     Document Type: Review

References (39)

1. Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday VA, Borum R. Can involuntary outpatient commitment reduce hospital recidivism? Findings from a randomized trial with severely mentally ill individuals. Am J Psychiatry 1999; 156: 1968-1975
2. Torrey EF, Kaplan RJ. A national survey of the use of outpatient commitment. Psychiatr Serv 1995; 46: 778-784
3. Gray JE, O'Reilly RL. Canadian compulsory community treatment laws: recent reforms. Int J Law Psychiatry 2005; 28: 13-22.
4. Steadman HJ, Gounis K, Dennis D, Hopper K, Roche B, Swartz M, et al. Assessing the New York City involuntary outpatient commitment pilot program. Psychiatr Serv 2001; 52: 330-336 (Pubitemid 32259666)
5. Swartz MS, Swanson JW. Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data? Can J Psychiatry 2004; 49: 585-591
6. Szmukler G, Hotopf M. Effectiveness of involuntary outpatient commitment. Am J Psychiatry 2001; 158: 653-654
7. O'Reilly R, Bishop J. Assessing the New York City involuntary outpatient treatment program. Psychiatr Serv 2001; 52: 1533-1534
8. Kisely S, Campbell LA, Preston N. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev 2005; (3): CD004408.
9. Churchill R, Owen D, Singh S, Hotopf M. International Experiences of Using Community Treatment Orders. UK Department of Health, 2007.
10. Sensky T, Hughes T, Hirsch S. Compulsory psychiatric treatment in the community. II. A controlled study of patients whom psychiatrists would recommend for compulsory treatment in the community. Br J Psychiatry 1991; 158: 799-804.
11. Ridley G. Community treatment orders. Br J Psychiatry 1993; 163: 417.
12. Department of Health. Mental Health Act 2007. UK Department of Health, 2007 (http://www.opsi.gov.uk/acts/acts2007/pdf/ukpga-20070012-en.pdf).
13. Mental Welfare Commission for Scotland. Annual Report to Members. Mental welfare Commission for Scotland, 2007 (http://www.kingsfund.org.uk/publications/ kings-fund-publications/a-question-of-1.html).
14. Lawton-Smith S. A Question of Numbers: The Potential Impact of Community-Based Treatment Orders in England and Wales. King's Fund, 2007 (http://www.kingsfund.org.uk/publications/kings-fund-publications/ a-question-of-1.html).
15. Barnes TRE, Curson DA. Long-term depot antipsychotics: a risk-benefit assessment. Drug Saf 1994; 10: 464-479
16. Davis JM, Matalon L, Watanabe MD, Blake L, Matalon L. Depot antipsychotic drugs. Place in therapy. Drugs 1994; 47: 741-773
17. Dignam P. Ethics of community treatment orders (letter). Aust N Z J Psychiatry 1998; 32: 890. (Pubitemid 29086137)
18. Levine J, Schooler NR, Cassano GB. The role of depot neuroleptics in the treatment of schizophrenic patients. Psychol Med 1979; 9: 383-386 (Pubitemid 9198807)
19. Patel MX, David AS. Why aren't depot antipsychotics prescribed more often and what can be done about it? Advan Psychiatr Treat 2005; 11: 203-211
20. Hardman AE. Community treatment order in Australia. Br J Psychiatry 1993; 162: 710.
21. McLaren S, Cookson J. Community treatment orders for mental illness (letter). Lancet 1989; II: 1457. (Pubitemid 20012098)
22. Pinfold V, Bindman J, Thornicroft G, Franklin D, Hatfield B. Persuading the persuadable: evaluating compulsory treatment in England using Supervised Discharge Orders. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 260-266 (Pubitemid 32694472)
23. Callaly T, Trauer T. Patterns of use of antipsychotic medication in a regional community mental health service. Australes Psychiatry 2000; 8: 220-224 (Pubitemid 30802023)
24. Vaughan K, Mcconaghy N, Wolf C, Myhr C, Black T. Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission. Aust N Z J Psychiatry 2000; 34: 801-808 (Pubitemid 30752872)
25. Muirhead DR, Ingram G, Harvey C. Effectiveness of community treatment orders for treatment of schizophrenia with oral or depot antipsychotic medication: clinical outcomes. Aust N Z J Psychiatry 2006; 40: 596-605. (Pubitemid 43805631)
26. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis 1996; 184: 653-659 (Pubitemid 27006435)
27. Garavan J, Browne S, Gervin M, Lane A, Larkin C, O'Callaghan E. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry 1998; 39: 215-219 (Pubitemid 28326194)
28. Department of Human Services. Involuntary Patients. About Your Rights. Mental Health Branch, Victorian Government Dept of Human Services, 2004.
29. Brophy LM, Reece JE, McDermott F. A cluster analysis of people on Community Treatment Orders in Victoria, Australia. Int J Law Psychiatry 2006; 29: 469-481 (Pubitemid 44750217)
30. Singh BS. Mainstreaming psychiatric services. Med J Australia 1992; 156: 373-374
31. Lambert TJR. The use of depot antipsychotics in community psychiatry. PhD dissertation, University of Melbourne, 2005.
32. Goldberg D. Impressions of psychiatry in Australia. Australes Psychiatry 2000; 8: 307-311
33. Dawson J. Fault-lines in community treatment order legislation. Int J Law Psychiatry 2006; 29: 482-494 (Pubitemid 44750218)
34. Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday VA. Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. J Nerv Ment Dis 2001; 189: 583-592
35. Appelbaum PS. Law and psychiatry: dangerous persons, moral panic, and the uses of psychiatry. Psychiatr Serv 2003; 54: 441-442
36. Lambert T, de Castella A, Kulkarni J, Ong AN, Singh B. One year estimate of depot antipsychotic adherence and readmission in Australian community mental health settings. Schizophr Bull 2007; 33: 485.
37. Hogarty GE, Schooler NR, Ulrich R, Mussare F, Ferro P, Herron E. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Arch Gen Psychiatry 1979; 36: 1283-1294
38. Kisely S, Campbell LA, Scott A, Preston NJ, Xiao J. Randomized and non-randomized evidence for the effect of compulsory community and involuntary out-patient treatment on health service use: systematic review and meta-analysis. Psychol Med 2007; 37: 3-14. (Pubitemid 46043838)
39. Hale T. Will the new antipsychotics improve the treatment of schizophrenia? BMJ 1993; 307: 749-750